BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6531445)

  • 1. Platelet 3H-imipramine binding: a state-dependent marker in depression.
    Suranyi-Cadotte B; Quirion R; McQuade P; Nair NP; Schwartz G; Mosticyan S; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):737-41. PubMed ID: 6531445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet 3H imipramine binding: a possible predictor of response to antidepressant treatment.
    Hrdina PD; Lapierre YD; Horn ER; Bakish D
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):619-23. PubMed ID: 3003804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers.
    Raisman R; Sechter D; Briley MS; Zarifian E; Langer SZ
    Psychopharmacology (Berl); 1981; 75(4):368-71. PubMed ID: 6803282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in human platelet 3H-imipramine binding.
    Tang SW; Morris JM
    Psychiatry Res; 1985 Oct; 16(2):141-6. PubMed ID: 3865254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
    Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
    Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3H-imipramine platelet binding sites in unipolar depression.
    Baron M; Barkai A; Gruen R; Kowalik S; Quitkin F
    Biol Psychiatry; 1983 Dec; 18(12):1403-9. PubMed ID: 6661469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protein concentration on kinetic constants (Kd and Bmax) of 3H-imipramine binding in blood platelets.
    Arora RC; Wunnicke V; Meltzer HY
    Biol Psychiatry; 1985 Jan; 20(1):116-9. PubMed ID: 2981127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between seasonal patterns of platelet serotonin uptake and 3H-imipramine binding in depressed patients and normal controls.
    Chicz-DeMet A; Reist C; DeMet EM
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):25-39. PubMed ID: 2008538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3H-imipramine binding in depressed elderly: relationship to family history and clinical response.
    Schneider LS; Fredrickson ER; Severson JA; Sloane RB
    Psychiatry Res; 1986 Dec; 19(4):257-66. PubMed ID: 3809324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
    Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D
    Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
    Lawrence KM; Falkowski J; Jacobson RR; Horton RW
    Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet [3H]imipramine binding in affective disorders: trait versus state characteristics.
    Baron M; Barkai A; Gruen R; Peselow E; Fieve RR; Quitkin F
    Am J Psychiatry; 1986 Jun; 143(6):711-7. PubMed ID: 3717391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.
    Suranyi-Cadotte BE; Quirion R; Nair NP; Lafaille F; Schwartz G
    Life Sci; 1985 Feb; 36(8):795-9. PubMed ID: 3974410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment.
    Gronier B; Azorin JM; Dassa D; Jeanningros R
    Eur Neuropsychopharmacol; 1994 Mar; 4(1):7-14. PubMed ID: 8204999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet [3H]imipramine binding in depressed patients and its circadian variations in healthy controls.
    Nankai M; Yoshimoto S; Narita K; Takahashi R
    J Affect Disord; 1986; 11(3):207-12. PubMed ID: 3031144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential 3H-imipramine platelet binding in patients with panic disorder and depression.
    Innis RB; Charney DS; Heninger GR
    Psychiatry Res; 1987 May; 21(1):33-41. PubMed ID: 3037580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet [3H]-imipramine binding according to DSM-III subtypes of depression.
    Jeanningros R; Gronier B; Azorin JM; Tissot R
    Neuropsychobiology; 1989; 22(1):33-40. PubMed ID: 2561683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.
    DeMet EM; Gerner RH; Bell KM; Kauffmann CD; Chicz-DeMet A; Warren S
    Biol Psychiatry; 1989 Sep; 26(5):478-88. PubMed ID: 2551399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.